Alvogen Prevails On US Zohydro ER Appeal

Two Patents Protecting Hydrocodone Brand Are Invalid

Hydrocodone
Two US patents protecting Persion's Zohydro extended-release hydrocodone formulation are invalid • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin